Will non-drug research proposals be considered?

Will non-drug research proposals be considered?
Yes. Post-hoc exploratory and well-designed retrospective or prospective evaluations to generate and/or test hypotheses or studies to validate new assessments will be considered for the 2017 ASPIRE TTR Amyloidosis program provided the study is designed to generate data to better understand important diagnostic and clinical management issues relevant to treating patients with TTR Amyloidosis. Evaluations may include standardized assessments as well as surrogate biomarkers that may define or predict clinical response and to identify novel diagnostic strategies. (top)

FAQ Category:

FAQ Tag: 
nondrug